Latest News about MRK
Recent news which mentions MRK
2 Beaten-Down Healthcare Stocks to Buy Hand Over Fist
November 21, 2024
From Motley Fool
Merck's Multi-Billion Dollar Drug Keytruda's Investigational Under The Skin Injection At Par With Intravenous Formulation In Untreated Lung Cancer Patients
November 19, 2024
From Benzinga
Powell Speaks The Truth - Market Does Not Like It, Consternation About Kennedy, Gaetz, And Hegseth
November 15, 2024
From Benzinga
European And US Vaccine Stocks Are Under Pressure - Here's WHy
November 15, 2024
From Benzinga
Immutep's Lead Cancer Drug Shows Promising 2-Year Survival Data In Lung Cancer Trial
November 14, 2024
From Benzinga
From Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
November 13, 2024
From Benzinga
3 Stocks Poised for a Breakout
November 09, 2024
From Motley Fool
Bristol-Myers Squibb Leads Biopharma Recovery With Almost 25% Growth In Market Cap, But Novo Nordisk And Lilly Suffer Market Setbacks
November 08, 2024
From Benzinga
2 Hot Biopharma Stocks to Buy and Hold for 5 Years
November 08, 2024
From Motley Fool
Got $5,000? These 3 Growth Stocks Are Trading Near Their 52-Week Lows.
November 07, 2024
From Motley Fool
Moderna Gears Up For Q3 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts
November 07, 2024
From Benzinga
Jim Cramer: This Financial Stock Is A Buy, Likes Broadcom
November 06, 2024
From Benzinga
2 Magnificent Stocks to Buy That Are Near 52-Week Lows
November 05, 2024
From Motley Fool
Summit Therapeutics 'Unique Investment In Oncology,' Lead Drug Candidate Shows Promise Over Keytruda And Opdivo
November 04, 2024
From Benzinga
Is Pfizer Stock a Bargain for Long-Term Investors?
November 04, 2024
From Motley Fool
Is It Time to Buy October's Worst-Performing Dow Jones Stocks?
November 03, 2024
From Motley Fool
3 Magnificent Stocks Under $100 to Buy in November
November 03, 2024
From Motley Fool
2 Dividend Stocks to Buy for a Lifetime of Passive Income
November 02, 2024
From Motley Fool
Merck's Gardasil Shot Challenges To Continue, Analysts Optimistic For Newly Approved Sotatercept For Rare Lung Disease
November 01, 2024
From Benzinga
Stocks Tumble, Nasdaq 100 Selloffs As Tech Giants Disappoint, Crypto Companies Plummet: What's Driving Markets Thursday?
October 31, 2024
From Benzinga
Merck Beats Q3 Estimates, But Lowers Annual Forecast As Gardasil Vaccine Hit By Low China Demand
October 31, 2024
From Benzinga
3 Dividend Stocks That Could Raise Their Payouts in November
October 31, 2024
From Motley Fool
A Look Into Merck & Co Inc's Price Over Earnings
October 29, 2024
From Benzinga
Why Is Moderna Stock Trading Higher On Monday?
October 28, 2024
From Benzinga
Pfizer, Live Nation Entertainment And More On CNBC's 'Final Trades'
October 25, 2024
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.